RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQ: RAPP · HEALTHCARE · BIOTECHNOLOGY
$33.00
-2.19% today
Updated 2026-04-29
Market cap
$1.58B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$8 – $42
Volume
0.3M
Rapport Therapeutics, Inc. Common Stock (RAPP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-28.20%
ROA
-18.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | — | $-10.65M | — | — | — |
| 2023 | $0.00 | $-34.79M | — | — | — |
| 2024 | $0.00 | $-78.31M | — | — | — |
| 2025 | $0.00 | $-111.48M | — | — | — |